A New Haemostatic Agent's Effect on the Success of Calcium Hydroxide Pulpotomy in Primary Molars

Odabas M. E., Cinar Ç., Tulunoglu O., Isik B.

PEDIATRIC DENTISTRY, cilt.33, sa.7, ss.529-534, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 7
  • Basım Tarihi: 2011
  • Dergi Adı: PEDIATRIC DENTISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.529-534
  • Anahtar Kelimeler: PULPOTOMY, HAEMOSTATIC AGENT, CALCIUM HYDROXIDE, ANKAFERD BLOOD STOPPER, MINERAL TRIOXIDE AGGREGATE, CONTROLLED CLINICAL-TRIAL, ADHESIVE SYSTEM, PULP THERAPY, DENTAL-PULP, IN-VITRO, FORMOCRESOL, MANAGEMENT, EFFICACY
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose: The purpose of this study was to evaluate the effect of the application of a new hemostatic agent, Ankaferd Blood Stopper (ABS), on the clinical and radiographic success of calcium hydroxide (CH) pulpotomies in primary molars. Methods: Patients with bilateral vital mandibular primary molar teeth that required pulpotomies, because of pulpal exposure to caries, were selected for this study After initial hemorrhage control, complete hemostasis into the canal orifice was achieved by: (1) applying a solution of ABS for 10 to 15 seconds; or (2) placing sterile, saline-wetted cotton pellets. Forty teeth in 2 groups were followed up clinically and radiographic at 1, 3, 6, 9, and 12 months. Results: CH group teeth had a total success rate of 90% at 12 months. CH+ABS group teeth had a total success rate of 95% at 12 months. There were no statistically significant differences between CH and CH+ABS group regarding both clinical and radiographic success rates. Conclusion: Ankoferd Blood Stopper may be a useful product in the management of pulpal bleeding during a calcium hydroxide pulpotomy. (Pediatr Dent 2011;33:529-34) Received April 7 2010 vertical bar Last Revision August 7, 2010 vertical bar Accepted August 8, 2010